New test would show if dengue vaccine safe for patientFebruary 16th, 2009 - 6:04 pm ICT by IANS
Washington, Feb 16 (IANS) Researchers have developed a test to determine whether vaccines against a virus that infects 100 million people annually, now ready for clinical trials, should really protect patients from infection, or would make it more dangerous for them.
“Our study shows that the new test is likely superior to the standard test in its ability to tell whether a patient’s response to a vaccine is safe,” said Xia Jin, associate professor of medicine at the University of Rochester Medical Centre (URMC) and co-author of the study.
Cases of tropical, mosquito-borne dengue fever have been expanding globally for more than 50 years, with nearly a third of the human population in 100 countries now at risk of infection with the four types of dengue virus.
Infection with the dengue flavivirus, which is related to West Nile Virus and Yellow Fever, annually results in an estimated half a million hospitalisations and 22,000 deaths, mostly among infants, according to WHO.
After decades of absence in the US, the disease is causing illness again along the Texas-Mexico border, experts say and add that widespread dengue infection in the continental US is a real possibility.
A typical dengue infection confines a patient to bed for more than a week with fever and severe limb pains, but most recover. In less than five percent of cases, however, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), often deadly complications, develop just as the fever breaks.
Mostly affecting babies between five and eight months, DHF causes victims to vomit and pass blood in their feces and urine. If diagnosed quickly, patients respond to intensive hospital treatment and fluids, but mortality can reach 15 percent when undiagnosed.
DSS comes when the infection has caused so much fluid to leak out of capillaries that there is not enough blood to supply organs. As of 2008, there were no antiviral drugs designed to treat dengue and no drug candidates in late-stage development, said an URMC release.
These findings were published in Clinical and Vaccine Immunology.
- Hypothesis on mystery of dengue virus infection confirmed - Feb 12, 2010
- World's first dengue vaccine to be released soon - Apr 25, 2010
- Two gene variants in dengue identified - Oct 18, 2011
- US man is world's first to sexually transmit insect-borne disease to wife - Apr 09, 2011
- Lahore dengue toll rises to 36 - Sep 18, 2011
- Coming soon: A trap to trick pregnant mosquitoes! - Dec 26, 2010
- Built-in dengue virus killer found in humans - Jun 24, 2012
- Canada launches global study to find dengue cure - Jul 16, 2010
- Vaccine against four dengue strains to go on trial - Sep 26, 2010
- Incurable mosquito virus hits Australia - May 18, 2011
- Pakistan to get insecticide from India to fight dengue - Sep 21, 2011
- New finding may help in dengue fever fight - May 07, 2010
- New therapy could help beat Hepatitis C virus - Jan 17, 2012
- Discovery enables quicker diagnosis of chikunguyna - Mar 15, 2012
- West Nile virus hits US, four dead - Aug 04, 2012
Tags: antiviral drugs, capillaries, dhf, feces, flavivirus, half a million, human population, limb pains, medical centre, mexico border, new test, rochester medical, shock syndrome, types of dengue virus, university of rochester, urmc, virus infection, west nile virus, xia jin, yellow fever